Literature DB >> 1937779

Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis.

L Beaman1.   

Abstract

Human peripheral blood monocytes readily phagocytized Coccidioides immitis endospores (2 to 5 microns) in vitro. Within 24 to 30 h at 37 degrees C, the phagocytized endospores started developing into immature spherules. However, when the monocytes were incubated with recombinant human gamma interferon (rIFN-gamma) or recombinant human tumor necrosis factor alpha (rTNF-alpha) and then infected, fewer endospores developed into spherules. Treatment with rIFN-gamma or rTNF-alpha activated the fungicidal capabilities of the monocytes as evidenced by the significant reduction in CFU that could be recovered from rIFN-gamma- or rTNF-alpha-activated monocytes compared with nontreated controls.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937779      PMCID: PMC259020          DOI: 10.1128/iai.59.11.4227-4229.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines.

Authors:  H B LEVINE; J M COBB; C E SMITH
Journal:  Trans N Y Acad Sci       Date:  1960-04

2.  The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma.

Authors:  J Fleischmann; B Wu-Hsieh; D H Howard
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

3.  Role of lymphocytes in macrophage-induced killing of Coccidioides immitis in vitro.

Authors:  L Beaman; E Benjamini; D Pappagianis
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

4.  Fungicidal activation of murine macrophages by recombinant gamma interferon.

Authors:  L Beaman
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Induction of tumor necrosis factor alpha by spherules of Coccidioides immitis.

Authors:  D C Slagle; R A Cox; U Kuruganti
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon.

Authors:  B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

7.  Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis.

Authors:  L Beaman; E Benjamini; D Pappagianis
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon.

Authors:  K Watanabe; K Kagaya; T Yamada; Y Fukazawa
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.

Authors:  E Brummer; C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  In vitro response of alveolar macrophages to infection with Coccidioides immitis.

Authors:  L Beaman; C A Holmberg
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

  10 in total
  18 in total

1.  Pulmonary aspergillosis after treatment with infliximab in Still's disease and a literature review of Still's disease and pulmonary aspergillosis.

Authors:  Emrah Şeyhoğlu; Abdülsamet Erden; Levent Kılıç; Ömer Karadağ; Sevtap Arıkan Akdağlı; Ali Akdoğan; Umut Kalyoncu
Journal:  Eur J Rheumatol       Date:  2018-03

2.  Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis.

Authors:  Donald C Vinh; Brian Schwartz; Amy P Hsu; David J Miranda; Patricia A Valdez; Danielle Fink; Karen P Lau; Debra Long-Priel; Douglas B Kuhns; Gulbu Uzel; Stefania Pittaluga; Susan Hoover; John N Galgiani; Steven M Holland
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

3.  Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.

Authors:  C R Zimmermann; S M Johnson; G W Martens; A G White; B L Zimmer; D Pappagianis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 5.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis.

Authors:  D M Magee; R A Cox
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis.

Authors:  R A Cox; D M Magee
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 8.  Coccidioidomycosis.

Authors:  J N Galgiani
Journal:  West J Med       Date:  1993-08

Review 9.  Valley fever: danger lurking in a dust cloud.

Authors:  Larry Johnson; Erin M Gaab; Javier Sanchez; Phuong Q Bui; Clarissa J Nobile; Katrina K Hoyer; Michael W Peterson; David M Ojcius
Journal:  Microbes Infect       Date:  2014-07-16       Impact factor: 2.700

10.  Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Authors:  K E Zucker; P Kamberi; R A Sobel; G Cloud; D N Meli; K V Clemons; D A Stevens; P L Williams; S L Leib
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.